Luv these last two lines .....
Mayne Pharma directly markets more than 55 products and has a growing pipeline of approximately 30 products targeting US markets with IQVIA sales greater than US$5 billion.
Morningstar has 5-star "Strong Buy" rating for MYX.
I'm sure this going to be $2 in one year! MYX is awakening up!!
Ann: Mayne Pharma's generic NuvaRing accepted for filing by FDA, page-2
Add to My Watchlist
What is My Watchlist?
